Concepedia

Publication | Open Access

ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer

51

Citations

30

References

2016

Year

Abstract

CRT combined with nelfinavir showed acceptable toxicity and promising survival in pancreatic cancer.

References

YearCitations

Page 1